Aclaris Therapeutics Inc. added Andrew Schiff to its board.
Schiff is a managing partner at Aisling Capital LLC.
Aclaris Therapeutics adds director
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Aclaris Therapeutics adds director
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals